Polineuropatia motora em cão adulto / Motor polyneuropathy in an adult dog

Background: Nonambulatory flaccid tetraparesis can be the result of diseases of the peripheral nervous system and it is characterized by generalized lower motor neuron (LMN) signs, as weakness, tetraparesis/tetraplegia, decreased muscle tone and reflexes. The term polyneuropathy is used for dysfunction of multiple peripheral nerves. In Brazil, there are several etiologies for polyneuropathy in dogs, such as acute idiopathic polyradiculoneuritis, botulism and myasthenia gravis. Toxoplasma gondii is an uncommon cause of LMN diseases in dogs. The aim of this report was to describe a case of flaccid tetraplegia toxoplasmosis in an adult dog with a Toxoplasma gondii serology with a markedly elevated IgG titer of 1:4096. Case: A 4-year-old intact mongrel male dog, weighing 19.6 kg, was referred to the Veterinary Medical Teaching Hospital of the Universidade Estadual de Londrina (UEL) with a 5-day history of weakness that progressed to tetraparesis. Physical examination revealed no significant changes other than the dull and unkempt coat. Neurologic examination revealed severe tetraparesis that was worse in the pelvic limbs, with decreased muscle tone in all four limbs. Postural reactions and the interdigital reflex were absent in all four limbs, as was the patellar reflex, but pain perception was present. There were no clinical signs of dysfunction on examination of the cranial nerves. Laboratory tests were performed, and creatine kinase was elevated (819 U/L). Blood was drawn to look for antibodies to Toxoplasma gondii and Neospora caninum class IgG using the indirect immunofluorescence technique. The antibody titer for Toxoplasma gondii (IgG) was 1:4096. A chest radiograph was performed to look for megaesophagus, and a pulmonary pattern suggestive of mild diffuse pneumonia was observed. Treatment was performed with sulfamethoxazole and trimethoprim, and the dog's condition improved slightly. Discussion: Based on lower motor neuron findings, the neurologic lesion was localized in the nerve roots, peripheral nerves, neuromuscular junctions, or muscles. The most important diseases in the list of differential diagnoses were immune-mediated or infectious polyradiculoneuritis (toxoplasmosis, neosporosis), myasthenia gravis, toxic polyneuropathy (botulism, chronic organophosphate poisoning), and paraneoplastic polyneuropathy. Among these differential diagnoses, polyradiculoneuritis is one of the most common. It is an idiopathic inflammatory disease. Exposure to raccoon saliva (in the U.S.), vaccination, or infection have been proposed as precipitating causes, but the triggers of this disease remain unknown. Serology for neosporosis was negative, while IgG titers for toxoplasmosis were 1:4096. In a previous study, dogs with acute polyradiculoneuritis were more likely to have T. gondii IgG serum antibody titers than dogs without neurologic signs. Infection with the protozoa T. gondii and N. caninum can cause intense polyradiculoneuritis in dogs accompanied by myositis, especially in puppies. One treatment trial was based on the administration of sulfonamide-trimethoprim with pyrimethamine, whose efficacy in the treatment of toxoplasmosis in dogs has also been reported in the literature. Neurologic deficits improved slightly, and there is a possibility that certain signs may not disappear completely because of the permanent damage caused by inflammation of the nervous system, as observed in the present case. The case had the limitation that it was not possible to perform other laboratory tests to demonstrate histopathologically the presence of Toxoplasma gondii organisms in muscles or nerves. Recovery of normal function is less likely in protozoan polyradiculoneuritis than in noninfectious polyradiculoneuritis. Thus, in the present case, the main suspicion was polyradiculoneuritis secondary to toxoplasmosis. Although it is a rare condition, it is important to consider toxoplasmosis in dogs with LMN-type tetraparesis or tetraplegia.

Treatment of chronic immunomediated thrombocytopenia with mesenquimal stem cells in dog: case report / Tratamento de trombocitopenia imunomediada crônica com células-tronco mesenquimais em cão: relato de caso

Immunomediated thrombocytopenia is a systemic metabolic disorder in which the platelet count falls below reference values, as the patient's immune system destroys them. The main clinical signs in thrombocytopenia are petechial, hemorrhages, ecchymoses and suffusions. Hematomas can also occur in coagulation disorders. The diagnosis is based on clinical findings and hematological examinations. The treatment consists of the use of corticosteroids and immunosuppressants, delaying cell destruction, and may last for months, not always obtaining a cure for the disease. The present work reports the use of therapy with allogeneic mesenchymal stem cells, derived from the adipose tissue of dogs, for the treatment of chronic immunomediated thrombocytopenia, with an evolution of more than one year, in a Pinscher dog. The alternative treatment showed a good evolution, keeping platelets within the reference values during the treatment, giving the patient quality of life and removing the need for continuous medication for homeostasis after treatment.

A trombocitopenia imunomediada é uma desordem metabólica sistêmica, na qual a contagem plaquetária fica abaixo dos valores de referência, pois o sistema imunológico do paciente a destrói. O principal sinal clínico na trombocitopenia são hemorragias, petequiais, equimoses e sufusões. Hematomas podem ocorrer também em alterações da coagulação. O diagnóstico baseia-se nos achados clínicos e nos exames hematológicos. O tratamento consiste na utilização de corticosteroides e imunossupressores, o que retarda a destruição celular, mas pode se prolongar por meses, nem sempre obtendo cura da doença. O presente trabalho relata a utilização da terapia com células-tronco mesenquimais alogênicas, oriundas do tecido adiposo de cães, para tratamento de trombocitopenia imunomediada crônica, com evolução de mais de um ano, em um cão da raça Pinscher. O tratamento alternativo revelou boa evolução, pois manteve as plaquetas dentro dos valores de referência durante o tratamento, o que proporcionou qualidade de vida ao paciente e tornou desnecessárias medicações de uso contínuo para a homeostase após o tratamento.

Aspectos da hemoplasmose em búfalos: revisão bibliográfica / Aspects of hemoplasmosis in buffaloes: literature review / Aspectos de la hemoplasmosis en búfalos: revisión de la literatura

Búfalos são animais rústicos que podem ser explorados para a produção de carne ou leite. Estes animais são susceptíveis a enfermidades que também acometem outras espécies de ruminantes, principalmente os bovinos. Entretanto, acredita-se que os bubalinos sejam mais resistentes a algumas doenças, mas ainda há poucos estudos epidemiológicos abrangendo doenças infecciosas como a hemoplasmose em búfalos. A hemoplasmose é causada por micoplasmas hemotrópicos ou hemoplasmas, que são bactérias gram-negativas causadoras de anemia hemolítica em hospedeiros imunocomprometidos. Mycoplasma wenyonii e 'Candidatus Mycoplasma haemobos' são as principais espécies de hemoplasmas que podem infectar búfalos. A transmissão da doença ocorre principalmente por meio de vetores artrópodes hematófagos ou por via iatrogênica. O diagnóstico de animais infectados é realizado por meio da Reação em Cadeia da Polimerase (PCR). Medidas de prevenção e controle são essenciais para o controle desta enfermidade nos rebanhos bubalinos.

Buffalo are rustic animals that can be exploited for meat or milk production. These animals are susceptible to diseases that also affect other species of ruminants, especially cattle. However, it is believed that buffalo are more resistant to some diseases, but there are still few epidemiological studies covering infectious diseases such as hemoplasmosis in buffaloes. Hemoplasmosis is caused by hemotropic mycoplasmas or hemoplasmas, which are gram-negative bacteria that cause hemolytic anemia in immunocompromised hosts. Mycoplasma wenyonii and 'Candidatus Mycoplasma haemobos' are the main hemoplasma species that can infect buffaloes. Transmission of the disease occurs mainly via hematophagous arthropod vectors or iatrogenically. The diagnosis of infected animals is made by Polymerase Chain Reaction (PCR). Prevention and control measures are essential for the control of this disease in buffalo herds.

Los búfalos son animales rústicos que pueden ser explotados para la producción de carne o leche. Estos animales son susceptibles de contraer enfermedades que también afectan a otras especies de rumiantes, especialmente al ganado vacuno. Sin embargo, se cree que los búfalos son más resistentes a algunas enfermedades, pero todavía hay pocos estudios epidemiológicos sobre enfermedades infecciosas como la hemoplasmosis en búfalos. La hemoplasmosis está causada por micoplasmas hemotrópicos o hemoplasmas, que son bacterias gram negativas que causan anemia hemolítica en huéspedes inmunodeprimidos. Mycoplasma wenyonii y 'Candidatus Mycoplasma haemobos' son las principales especies de hemoplasma que pueden infectar a los búfalos. La transmisión de la enfermedad se produce principalmente a través de vectores artrópodos hematófagos o de forma iatrogénica. El diagnóstico de los animales infectados se realiza mediante la reacción en cadena de la polimerasa (PCR). Las medidas de prevención y control son esenciales para controlar esta enfermedad en los rebaños de búfalos.

Effect of electrophysical resources on healing of neurotendinous injury in an experimental model of type I diabetes and kidney disease

Purpose: To evaluate and describe the effect of electrophysical resources laser therapy (LLLT), intravascular laser blood irradiation (ILIB), and cryotherapy on the healing process of neurotendinous injury, as well as possible systemic changes, in the experimental model of type 1 diabetes associated with kidney injury. Methods: The animals were randomized into four groups: G1) healthy control with untreated injury; G2) healthy control with injury and treatment; G3) disease control with untreated lesion; G4) disease with injury and treatment. Furthermore, the treated groups were divided into three, according to the type of treatment. All animals were induced to neurotendinous injury and treated according to the therapeutic protocols. Healing and inflammation were analyzed by semiquantitative histopathological study. Results: It was observed in sick animals treated with cryotherapy and ILIB reduction of inflammatory exudate, presence of fibroblasts and organization of collagen, when compared to the effects of LLLT. Moreover, there was reduction in glycemic levels in the group treated with ILIB. Conclusions: Cryotherapy promoted reduction in inflammatory exudate and organization of collagen fibers, in addition to the absence of signs of tissue necrosis, in the groups treated with and without the disease. ILIB therapy showed the same findings associated with significant reduction in glycemic levels in the group of diseased animals. The application of LLLT showed increased inflammatory exudate, low organization of collagen fibers and low sign of tissue degeneration and necrosis. This study in a model of associated diseases (diabetes and kidney disease) whose effects of electrophysical resources studied after neurotendinous injury allows us to verify histopathological variables suggestive of patients with the same comorbidities.

Discoid lupus erythematosus in dog / Lúpus eritematoso discoide em cão

Lupus erythematosus complex is an immune-mediated dermatological disease, mainly represented by the generalized and discoid forms. The last form described is milder, as it is limited to the appearance of lesions, usually on the face and in mucocutaneous regions. Its pathophysiology is considered multifactorial, however, continuous exposure to ultraviolet radiation seems to be very relevant to trigger and/or worsen clinical manifestations. DeÞ nitive diagnosis is obtained by histopathological analysis, and treatment is mainly based on immunosuppression and protection against ultraviolet radiation. The objective of this study was to report the case and clinical evolution of a mixed breed bitch, diagnosed with discoid lupus erythematosus. The bitch presented moderate desquamation, crusts and depigmentation restricted to the nasal plane. No other clinical or laboratory Þ ndings were evidenced in the screening tests. Upon conÞ rmation by histopathology, the initial therapy was started with oral prednisolone. The owners were also instructed to avoid exposure to sunlight, as well as to use topical protectors against ultraviolet radiation. The patient presented good response to therapy, showing remission of signs. Other sporadic recurrences were observed later, however, they were controlled only with topical corticosteroids, but always reinforcing the other precautions of environmental management. This work also addressed the risks, beneÞ ts and need to institute ongoing care to control discoid lupus erythematosus. Therapeutic success can vary among patients, as the intensity of the disease can be manifested in varying degrees. Therefore, in those individuals in which the condition is mild, it may be advantageous to opt for more conservative therapies in order to avoid side effects.(AU)

O complexo lúpus eritematoso é uma enfermidade dermatológica imunomediada, sendo principalmente representado pela forma generalizada e discoide. A última descrita é mais branda, pois se limita ao aparecimento de lesões geralmente em face e em regiões muco-cutâneas. Sua Þ - siopatogenia é considerada multifatorial, entretanto, a exposição contínua à radiação ultravioleta parece ser muito relevante para desencadear e/ou agravar as manifestações clínicas. O diagnóstico deÞ nitivo é obtido pela análise histopatológica, e o tratamento se baseia principalmente na imunossupressão e proteção contra a radiação ultravioleta. O objetivo deste trabalho foi relatar o caso e evolução clínica de uma cadela sem raça deÞ nida, diagnosticada com lúpus eritematoso discoide. A mesma apresentou moderada descamação, crostas e despigmentação restritas ao plano nasal. Nenhum outro achado clínico ou laboratorial foi evidenciado nos demais exames de triagem. Após conÞ rmado pela histopatologia, a terapia inicial foi instituída a partir da prednisolona por via oral. Os tutores também foram orientados a evitar exposição a luz solar, bem como, fazer a utilização de protetores tópicos contra a radiação ultravioleta. A paciente teve boa resposta à terapia, apresentando remissão dos sinais. Após este episódio, outras recidivas esporádicas foram observadas, entretanto, controladas apenas com corticoides tópicos, mas sempre reforçando os demais cuidados com o manejo ambiental. Este trabalho também abordou os riscos, benefícios e necessidade de instituir o cuidado contínuo para controle do lúpus eritematoso discoide. O sucesso terapêutico pode variar entre os pacientes, uma vez que a intensidade da doença pode ser manifestada em vários graus. Portanto, naqueles indivíduos em que o quadro é brando, pode ser vantajoso optar por terapias mais conservadoras, a Þ m de evitar seus efeitos colaterais.(AU)

Anemia hemolítica imunomediada medicamentosa em uma cadela / Immune-mediated hemolytic anemia in a bitch triggered by drugs

Background: Immune-mediated hemolytic anemia (IMHA) is characterized by an autoimmune response with production of auto-antibodies and destruction of erythrocytes resulting in anemia. Primary IMHA is referred to a condition when the cause is unknown (idiopathic), whereas secondary IMHA involves changes in red blood cells caused by the action of drugs, neoplasms, or infectious diseases. The diagnosis can be made through changes in the blood count, usually of a regenerative character, Coombs test, and autoagglutination test. The present study aimed to report a case of drug-induced hemolytic anemia, with emphasis on the clinical signs, diagnostic methods, and treatment, in a female dog. Case: A 9-year-old mixed-breed bitch weighing 29.6 kg was referred to the Veterinary Medical Teaching Hospital (HCVUFRGS) with a previous diagnosis of gallbladder mucocele that was unresponsive to clinical treatment. After laboratory tests, cholecystectomy was performed, and the procedure required conversion from laparoscopic to open cholecystectomy. Therapy included administration of amoxicillin, dipyrone, tramadol hydrochloride, and meloxicam. Three days after surgery, the dog presented with apathy, lethargy, hyporexia, and a pale and subicteric mucosa. The patient developed hypochromic macrocytic anemia with reticulocytosis, spherocytosis, anisocytosis, and leukocytosis with neutrophilia. The result of the autoagglutination test was positive, confirming the diagnosis. All medications were suspended, and immunosuppressive treatment with dexamethasone was included, with a subsequent switch to prednisolone. After 10 days of treatment, the patient experienced significant improvement, and therapy was discontinued. Discussion: Based on the patient's history, the cause of the IMHA was secondary to drug administration, and it is not possible to distinguish if it was due to one or a combination of drugs, as they were all started and stopped simultaneously. The patient had hypothyroidism, which may have contributed to the production of antibodies against TSH receptors, blocking the hormone's action, thereby causing tissue damage due to T cell-mediated cytotoxicity and the effect of cytokines. The pale and subicteric mucosa, apathy, weakness, lethargy, exercise intolerance, and dyspnea resulted from extravascular hemolysis and bilirubin released from erythrocyte rupture with a subsequent decrease in the number of red blood cells, leading to oxygen transport deficiency. The diagnosis is based on the blood count and results of autoagglutination supported by the response to immunosuppressive therapy. Anemia results in increased production and release of precursor cells from the bone marrow, accompanied by reticulocytosis and increased mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC). The treatment of IMHA consists of supportive care and immunosuppressive therapy with corticosteroids to ensure suppression of the immune system, preventing response against erythrocytes. Initially, tramadol hydrochloride, dipyrone, and amoxicillin with potassium clavulanate were suspended to interrupt the cause of IMHA, and administration of dexamethasone in an immunosuppressive dose was started. Therefore, it is important to include drug-induced IMHA in the differential diagnosis of patients who present with anemia after using medications. Early diagnosis, initiation of therapy, and adequate care were important factors for the recovery of the animal.

Treatment of discoid lupus erythematosus in a dog with human intravenous immunoglobulin

Background: Discoid lupus erythematosus (DLE) is a common canine autoimmune skin disease, in which systemic manifestations are absent. Skin Lesions are usually present on the nasal planum, and characterised by erythema, depigmentation, erosion, ulceration, and crusting. The diagnosis is based on histopathological results, which should demonstrate lymphoplasmacytic lichenoid-interface dermatitis. Human intravenous immunoglobulin (hIVIg) has been used in veterinary medicine to treat cutaneous diseases including erythema multiforme, PF, and severe adverse cutaneous drug reactions. In human medicine, it has been effective to treat DLE. This report firstly describes the clinical response to hIVIg in a dog with DLE resistant to common immunosuppressive drugs. Case: A 5-year-old, intact female Shih Tzu presented with a 1-month history of slowly progressive black crusting on the nasal planum, chin, and claw. Based on the results of a dermatologic examination, superficial pyoderma was diagnosed. The skin lesions did not improve during and after anti-infective treatment. After removing the crusts, a skin biopsy was obtained from the muzzle. Histopathology of lesional skin biopsy specimens revealed lymphoplasmacytic interface dermatitis at the dermoepidermal junction. Microscopic examination also revealed vacuolar changes and pigmentary incontinence of the basal layer as a lichenoid tissue reaction. No mites or fungi were detected on the skin section. The absence of acantholytic cells excluded pemphigus foliaceus, which is also characterised by the lesions of the nasal planum. Based on the distribution of the lesions, histopathology and exclusion of other dermatoses, the dog was diagnosed with DLE. The skin lesions temporarily improved after treatment with prednisolone (2 mg/kg PO q12h). However, after tapering the dose of prednisolone, new black crusts developed on the nasal planum and claw. Although the dog was successively treated with other immunosuppressive drugs, including azathioprine, cyclosporin with dexamethasone, and mycophenolate mofetil, black crusts still remained. Due to the low efficacy of these immunosuppressive drugs, hIVIg was administered at 0.5 g/kg once daily for 4 days, for a total dose of 2 g/kg. During hIVIg administration, the crusted lesions gradually improved. After the hIVIg administration, the dog was treated with prednisolone (1 mg/kg PO q12h). The lesions were almost in complete remission at 21 days after an additional application of prednisolone. The skin lesions did not recur, and the treatment was eventually discontinued after 6 weeks of additional prednisolone application. Discussion: The standard treatment of canine DLE includes glucocorticoids, and second-line immunosuppressive drugs, such as azathioprine and cyclosporine, are usually added in cases resistant to steroids. This case suggests that hIVIg may be beneficial as an adjunctive treatment option for canine DLE, especially when the application of standard immunosuppressive drugs is limited due to adverse effects or low efficacy. There is evidence from several studies that the steroid-sparing effect of hIVIg is significant in human patients. In the current case, the effective dose of prednisolone was reduced to 2 mg/kg/day after hIVIg administration, and prednisolone therapy was finally discontinued completely. The hIVIg appears to lower the daily steroid dose requirement in this dog.

Lúpus eritematoso discoide em cão / Dischoid erythematosus lupus in dog

O Lúpus Eritematoso Discoide (LED) é uma doença autoimune que causa alterações no sistema tegumentar dos animais. Ela acomete cães, gatos, equinos e humanos. Sua etiologia ainda não é bem elucidada, mas acredita-se que fatores genéticos, hormonais e ambientais possam possivelmente desencadeá-la. Essa enfermidade é caracterizada por despigmentação, eritema e descamação nas áreas acometidas, podendo em casos crônicos úlceras serem observadas. Seu diagnóstico baseia-se nos resultados obtidos na anamnese, histórico, exame físico e no exame histopatológico. Por se tratar de uma doença autoimune não há cura definitiva, ocorre apenas o controle, que para tal, pode-se utilizar drogas imunossupressoras e restrição solar. Objetiva-se com presente trabalho relatar um caso de Lúpus Eritematoso Discoide em um cão. No caso relatado o animal apresentava lesões com aspecto eritematoso, descamativo e ulcerado, na região nasal, nos lábios e gengiva, região perianal e na região abdominal caudal. O diagnóstico confirmatório da doença foi realizado por meio do exame histopatológico. Como tratamento foi instituído a corticoterapia a base de prednisolona na dose de 2mg/kg, BID, por 10 dias, posteriormente a dose foi reduzida para 1mg/kg, BID, por mais 10 dias e depois 1mg/kg, em dias alternados, também foi recomendado a restrição solar. O animal respondeu positivamente ao tratamento instituído com melhora significativa dos sinais clínicos apresentados. Contudo, deve-se salientar que a terapêutica instituída com objetivo de controle, pois conforme já foi mencionado não há cura definitiva para a enfermidade.

Discoid Lupus Erythematosus (LED) is an autoimmune disease that causes changes in the integumentary system of animals. It affects dogs, cats, horses and humans. Its etiology is still not well understood, but it is believed that genetic, hormonal and environmental factors may possibly trigger it. This disease is characterized by depigmentation, erythema and desquamation in the affected areas, and in chronic cases ulcers may be observed. Its diagnosis is based on the results obtained in the anamnesis, history, physical examination and histopathological examination. Because it is an autoimmune disease, there is no definitive cure, only control occurs, for which, immunosuppressive drugs and solar restriction can be used. The objective of this work is to report a case of Discoid Lupus Erythematosus in a dog. In the case reported, the animal presented lesions with an erythematous, scaly and ulcerated aspect, in the nasal region, on the lips and gums, perianal region and in the caudal abdominal region. The confirmatory diagnosis of the disease was performed by means of histopathological examination. As treatment, prednisolone-based corticosteroids were administered at a dose of 2mg / kg, BID, for 10 days, then the dose was reduced to 1mg / kg, BID, for another 10 days and then 1mg / kg, every other day, as well. solar restriction was recommended. The animal responded positively to the treatment instituted with a significant improvement in the clinical signs presented. However, it should be noted that the therapy instituted for the purpose of control, as as already mentioned, there is no definitive cure for the disease.

Lúpus eritematoso discoide em cão / Dischoid erythematosus lupus in dog

O Lúpus Eritematoso Discoide (LED) é uma doença autoimune que causa alterações no sistema tegumentar dos animais. Ela acomete cães, gatos, equinos e humanos. Sua etiologia ainda não é bem elucidada, mas acredita-se que fatores genéticos, hormonais e ambientais possam possivelmente desencadeá-la. Essa enfermidade é caracterizada por despigmentação, eritema e descamação nas áreas acometidas, podendo em casos crônicos úlceras serem observadas. Seu diagnóstico baseia-se nos resultados obtidos na anamnese, histórico, exame físico e no exame histopatológico. Por se tratar de uma doença autoimune não há cura definitiva, ocorre apenas o controle, que para tal, pode-se utilizar drogas imunossupressoras e restrição solar. Objetiva-se com presente trabalho relatar um caso de Lúpus Eritematoso Discoide em um cão. No caso relatado o animal apresentava lesões com aspecto eritematoso, descamativo e ulcerado, na região nasal, nos lábios e gengiva, região perianal e na região abdominal caudal. O diagnóstico confirmatório da doença foi realizado por meio do exame histopatológico. Como tratamento foi instituído a corticoterapia a base de prednisolona na dose de 2mg/kg, BID, por 10 dias, posteriormente a dose foi reduzida para 1mg/kg, BID, por mais 10 dias e depois 1mg/kg, em dias alternados, também foi recomendado a restrição solar. O animal respondeu positivamente ao tratamento instituído com melhora significativa dos sinais clínicos apresentados. Contudo, deve-se salientar que a terapêutica instituída com objetivo de controle, pois conforme já foi mencionado não há cura definitiva para a enfermidade.(AU)

Discoid Lupus Erythematosus (LED) is an autoimmune disease that causes changes in the integumentary system of animals. It affects dogs, cats, horses and humans. Its etiology is still not well understood, but it is believed that genetic, hormonal and environmental factors may possibly trigger it. This disease is characterized by depigmentation, erythema and desquamation in the affected areas, and in chronic cases ulcers may be observed. Its diagnosis is based on the results obtained in the anamnesis, history, physical examination and histopathological examination. Because it is an autoimmune disease, there is no definitive cure, only control occurs, for which, immunosuppressive drugs and solar restriction can be used. The objective of this work is to report a case of Discoid Lupus Erythematosus in a dog. In the case reported, the animal presented lesions with an erythematous, scaly and ulcerated aspect, in the nasal region, on the lips and gums, perianal region and in the caudal abdominal region. The confirmatory diagnosis of the disease was performed by means of histopathological examination. As treatment, prednisolone-based corticosteroids were administered at a dose of 2mg / kg, BID, for 10 days, then the dose was reduced to 1mg / kg, BID, for another 10 days and then 1mg / kg, every other day, as well. solar restriction was recommended. The animal responded positively to the treatment instituted with a significant improvement in the clinical signs presented. However, it should be noted that the therapy instituted for the purpose of control, as as already mentioned, there is no definitive cure for the disease.(AU)

Pemphigus foliaceous in a dog - clinical and laboratorial assessment

Background: The pemphigus complex is defined as a group of blistering autoimmune diseases that affects skin and mucous membrane. Pemphigus foliaceous is the most common disease in this group, being characterized by the productionof autoantibodies against keratinocyte adhesion molecules. The treatment is based on the use of immunosuppressive drugsand requires constant monitoring to assess inflammatory control as well as side effects of therapy. Based on that, the aimof this study was to report the clinical and laboratorial follow-up of a canine with pemphigus foliaceous.Case: An 11-year-old male neutered mongrel dog, weighing 9.8 kg, was presented with a main complaint related to disseminated pruritus and lesions in face, trunk and limbs. Dermatological examination revealed meliceric crusts, epidermalcollars and diffuse pustules in inguinal, abdominal, face, limbs, ears and thoraco-lumbar regions. Cytological examinationwas performed, revealing inflammatory and acantholytic cells and absence of bacterial cells. Biopsy procedure revealedsubcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatible with canine pemphigusfoliaceous. Hemato-biochemical analysis revealed a leukocytosis due to increased neutrophil count. Systemic treatmentwith high dose of prednisolone (2.0 mg/kg) and azathioprine (2.5 mg/kg) was proposed, while topical therapy with a 3%chlorhexidine shampoo was used to prevent secondary bacterial infections. The patient improved the dermatological clinicalsigns, being possible to observe a reduction of systemic and tissue inflammatory process. After 90 days of therapy, therewas a partial loss of hair body coverage, associated with follicular lesions, and after 180 days of therapy it was possibleto notice a new hair mantle, without visible areas of inflammation...

Pemphigus foliaceous in a dog - clinical and laboratorial assessment

Background: The pemphigus complex is defined as a group of blistering autoimmune diseases that affects skin and mucous membrane. Pemphigus foliaceous is the most common disease in this group, being characterized by the productionof autoantibodies against keratinocyte adhesion molecules. The treatment is based on the use of immunosuppressive drugsand requires constant monitoring to assess inflammatory control as well as side effects of therapy. Based on that, the aimof this study was to report the clinical and laboratorial follow-up of a canine with pemphigus foliaceous.Case: An 11-year-old male neutered mongrel dog, weighing 9.8 kg, was presented with a main complaint related to disseminated pruritus and lesions in face, trunk and limbs. Dermatological examination revealed meliceric crusts, epidermalcollars and diffuse pustules in inguinal, abdominal, face, limbs, ears and thoraco-lumbar regions. Cytological examinationwas performed, revealing inflammatory and acantholytic cells and absence of bacterial cells. Biopsy procedure revealedsubcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatible with canine pemphigusfoliaceous. Hemato-biochemical analysis revealed a leukocytosis due to increased neutrophil count. Systemic treatmentwith high dose of prednisolone (2.0 mg/kg) and azathioprine (2.5 mg/kg) was proposed, while topical therapy with a 3%chlorhexidine shampoo was used to prevent secondary bacterial infections. The patient improved the dermatological clinicalsigns, being possible to observe a reduction of systemic and tissue inflammatory process. After 90 days of therapy, therewas a partial loss of hair body coverage, associated with follicular lesions, and after 180 days of therapy it was possibleto notice a new hair mantle, without visible areas of inflammation...(AU)

Anemia hemolítica imunomediada primária em cães - Revisão de literatura / Primary immune-mediated hemolytic anemia in dogs - Literature review / Anemia hemolítica inmunomediada primaria en perros ­ Revisión de literatura

A anemia hemolítica imunomediada (AHIM) é o distúrbio imunológico de maior prevalência em cães. Caracteriza-se como uma hipersensibilidade do tipo II, que leva a destruição prematura de hemácias. Dentre as principais complicações, o estado de hipercoagulabilidade predispondo a coagulação intravascular disseminada e tromboembolismo pulmonar é a mais importante, sendo a causa de óbito em mais de 80% dos casos. O diagnóstico é realizado a partir da exclusão de outras causas para anemia e por meio da constatação de um ou mais desses sinais: anemia moderada a grave (hematócrito <25-35%), evidências de hemólise (hemoglobinemia, hemoglobinúria ou hiperbilirrubinemia) e presença de anticorpos na hemácia (caracterizado a partir da auto-aglutinação, esferocitose, teste de Coombs positivo ou citometria de fluxo). O tratamento é direcionado à supressão da resposta imune, sendo os corticosteroides e os imunossupressores, os fármacos de predileção.(AU)

Immune-mediated hemolytic anemia (IMHA) is the most prevalent immune disorder among dogs. It is characterized as type II hypersensitivity, leading to premature destruction of red blood cells. Among the main complications, hypercoagulability predisposing to disseminated intravascular coagulation and pulmonary thromboembolism is the most important, being the cause of death in more than 80% of the cases. The diagnosis is made by excluding other causes for anemia and the presence of one or more of these signs: moderate to severe anemia (hematocrit <25-35%), evidence of hemolysis (hemoglobinemia, hemoglobinuria or hyperbilirubinemia) and presence of antibodies in the erythrocyte (characterized by self-agglutination, spherocytosis, positive Coombs test, or flow cytometry). Treatment is directed to suppression of the immune response, with corticosteroids and immunosuppressants the drugs of predilection.(AU)

La anemia hemolítica inmunomediada (AHIM) es el disturbio inmunológico con mayor prevalencia en perros. Es definido como una hipersensibilidad tipo II, que lleva a destrucción prematura de hematíes. Dentro de las principales complicaciones, el estado de hipercoagulabilidad que predispone a coagulación intravascular diseminada y tromboembolismo pulmonar es el más importante, siendo la causa de muerte en más de 80% de los casos. El diagnóstico se realiza excluyendo otras causas de anemia y confirmando una o más de las siguientes alteraciones: anemia moderada a grave (hematocrito <25-35%), evidencias de hemolisis (hemoglobinemia, hemoglobinuria o hiperbilirrubinemia) y presencia de anticuerpos en hematíes (caracterizado a partir de autoaglutinación, esferocitosis, test de Coombs positivo o citometría de flujo). El tratamiento se basa en la supresión de la respuesta inmune, siendo los cortico esteroides y los inmunosupresores los fármacos de elección.(AU)

Perfil sensorial de bolo de chocolate sem glúten pelo método Check-all-that-apply (CATA) / Sensory profile of gluten-free chocolate cake by method Check-all-that-apply (CATA)

A doença celíaca é uma doença inflamatória autoimune do intestino delgado, desencadeada pela ingestão de glúten. O desenvolvimento de produtos isentos de glúten que apresentem boas características sensoriais se torna uma grande oportunidade para a indústria alimentícia. Nesse contexto, o objetivo deste trabalho foi desenvolver formulações de bolo de chocolate sem glúten e avaliar o perfil sensorial pelos consumidores. As formulações diferiram na proporção de farinha de arroz e dos diferentes substitutos das farinhas utilizados. Após garantir a segurança microbiológica, o produto foi caracterizado sensorialmente pelo método Check-all-that-apply (CATA) por 102 consumidores. A formulação F2 no teste CATA se assemelhou a F1. Dessa maneira, foi possível perceber que ambas formulações apresentaram características sensoriais desejáveis e podem ser uma boa alternativa para aqueles que desejam ou precisam de uma dieta isenta de glúten.(AU)

Perfil sensorial de bolo de chocolate sem glúten pelo método Check-all-that-apply (CATA) / Sensory profile of gluten-free chocolate cake by method Check-all-that-apply (CATA)

A doença celíaca é uma doença inflamatória autoimune do intestino delgado, desencadeada pela ingestão de glúten. O desenvolvimento de produtos isentos de glúten que apresentem boas características sensoriais se torna uma grande oportunidade para a indústria alimentícia. Nesse contexto, o objetivo deste trabalho foi desenvolver formulações de bolo de chocolate sem glúten e avaliar o perfil sensorial pelos consumidores. As formulações diferiram na proporção de farinha de arroz e dos diferentes substitutos das farinhas utilizados. Após garantir a segurança microbiológica, o produto foi caracterizado sensorialmente pelo método Check-all-that-apply (CATA) por 102 consumidores. A formulação F2 no teste CATA se assemelhou a F1. Dessa maneira, foi possível perceber que ambas formulações apresentaram características sensoriais desejáveis e podem ser uma boa alternativa para aqueles que desejam ou precisam de uma dieta isenta de glúten.

Obstrução da veia safena em equino por linfoma multicêntrico: relato de caso / Saphenous vein obstruction in horses due to multicentric lymphoma: case report

Os tumores hemolinfáticos são incomuns em cavalos, porém, o linfoma é o mais frequente deles. Os sinais clínicos variam dependendo da localização do tumor, sendo os mais comuns: depressão, perda progressiva de peso e linfadenopatia e anemia. O objetivo do presente estudo é relatar o caso de uma obstrução da veia safena por linfoma multicêntrico em uma égua de 13 anos, sem raça definida, apresentando ferida com tecido de granulação exuberante na região da articulação metatársica falangeana do membro posterior esquerdo, anemia e perda de peso. Devido ao estado debilitado e ao decúbito persistente, a égua foi eutanasiada. O exame pós-morte revelou um trombo mediu 15 cm de comprimento por 11 cm de diâmetro com aparência nodular e esbranquiçada. Em humanos, existe uma correlação entre doença linfoproliferativa e doença autoimune, pois o estímulo antigênico e a resposta inflamatória gerada pela doença autoimune pode ser capaz de transformar uma população de linfócitos policlonais em uma população monoclonal, compatível com uma linfoproliferação. No caso da égua, não houve doença autoimune, mas a inflamação crônica causada pela lesão da pitiose pode ter sido a causa do desenvolvimento do linfoma, já que este era único e no mesmo membro do tecido de granulação exuberante.

Hemolymphatic tumors are uncommon in horses, however, lymphoma is the most frequent of them. Clinical signs vary depending on the location of the tumor, with the most common being depression, progressive weight loss andlymphadenopathy, and anemia. The aim of this study is to report the case of an obstruction of saphenous vein bymulticentric lymphoma in a mare 13 years old, presenting wound with exuberant granulation tissue in the metatarsal phalangeal joint region of the left hind limb, anemia and loss of weight. Due to weakened state and persistent decubitus, the mare was euthanized. Postmortem examination revealed a thrombus measuring 15 cm in length by 11 cm in diameter with nodular and whitish appearance. In humans, there is a correlation between lymphoproliferative diseaseand autoimmune disease, since the antigenic stimulus and the inflammatory response generated by the autoimmune disease may be able to transform a population of polyclonal lymphocytes into a monoclonal population, compatible with a lymphoproliferation. In the case of mare, there was no autoimmune disease, but the chronic inflammation caused by pythiosis injury may have been the cause of lymphoma development, since lymphoma was unique and in the samelimb of exuberant granulation tissue.

Obstrução da veia safena em equino por linfoma multicêntrico: relato de caso / Saphenous vein obstruction in horses due to multicentric lymphoma: case report

Os tumores hemolinfáticos são incomuns em cavalos, porém, o linfoma é o mais frequente deles. Os sinais clínicos variam dependendo da localização do tumor, sendo os mais comuns: depressão, perda progressiva de peso e linfadenopatia e anemia. O objetivo do presente estudo é relatar o caso de uma obstrução da veia safena por linfoma multicêntrico em uma égua de 13 anos, sem raça definida, apresentando ferida com tecido de granulação exuberante na região da articulação metatársica falangeana do membro posterior esquerdo, anemia e perda de peso. Devido ao estado debilitado e ao decúbito persistente, a égua foi eutanasiada. O exame pós-morte revelou um trombo mediu 15 cm de comprimento por 11 cm de diâmetro com aparência nodular e esbranquiçada. Em humanos, existe uma correlação entre doença linfoproliferativa e doença autoimune, pois o estímulo antigênico e a resposta inflamatória gerada pela doença autoimune pode ser capaz de transformar uma população de linfócitos policlonais em uma população monoclonal, compatível com uma linfoproliferação. No caso da égua, não houve doença autoimune, mas a inflamação crônica causada pela lesão da pitiose pode ter sido a causa do desenvolvimento do linfoma, já que este era único e no mesmo membro do tecido de granulação exuberante.(AU)

Hemolymphatic tumors are uncommon in horses, however, lymphoma is the most frequent of them. Clinical signs vary depending on the location of the tumor, with the most common being depression, progressive weight loss andlymphadenopathy, and anemia. The aim of this study is to report the case of an obstruction of saphenous vein bymulticentric lymphoma in a mare 13 years old, presenting wound with exuberant granulation tissue in the metatarsal phalangeal joint region of the left hind limb, anemia and loss of weight. Due to weakened state and persistent decubitus, the mare was euthanized. Postmortem examination revealed a thrombus measuring 15 cm in length by 11 cm in diameter with nodular and whitish appearance. In humans, there is a correlation between lymphoproliferative diseaseand autoimmune disease, since the antigenic stimulus and the inflammatory response generated by the autoimmune disease may be able to transform a population of polyclonal lymphocytes into a monoclonal population, compatible with a lymphoproliferation. In the case of mare, there was no autoimmune disease, but the chronic inflammation caused by pythiosis injury may have been the cause of lymphoma development, since lymphoma was unique and in the samelimb of exuberant granulation tissue.(AU)

Pemphigus foliaceus in a sheep / Pênfigo foliáceo em uma ovelha

Pemphigus foliaceus (PF) is an autoimmune disease of the skin and is the most common form of pemphigus in domestic animals. This work reports a case of pemphigus foliaceus in a Santa Inês hair sheep. The ewe presented with multifocal bilateral crusted alopecic dermatitis affecting the chest, abdomen, and pelvic and thoracic limbs. Parakeratotic hyperkeratosis and acanthosis, in addition to subcorneal pustules, were observed histologically, and acantholytic cells and neutrophils were observed within the pustules. In the superficial and deep dermal tissues, there was intense eosinophilic infiltration and the presence of rare macrophages. These microscopic findings were characteristic of PF, and treatment with dexamethasone was ineffective. This disease is rare in sheep, and this is the first case report to be published in Brazil.(AU)

Pênfigo foliáceo (PF) é uma doença autoimune da pele e é a forma mais comum de pênfigo em animaisdomésticos. Este trabalho relata um caso de pênfigo foliáceo em uma ovelha Santa Inês. A ovelhaapresentava dermatite alopécica crostosa bilateral e assimétrica no tórax, abdômen, e membros pélvicose torácicos. Hiperceratose paraqueratótica e acantose, além de pústulas subcorneais, foram observadoshistologicamente, e células acantolíticas e neutrófilos foram observadas dentro das pústulas. Naderme superficial e profunda, havia intenso infiltrado de eosinófilos e raros macrófagos. Os achadosmicroscópicos são característicos de PF, e o tratamento com dexametasona foi ineficiente. Esta doençaé rara em ovinos e este é o primeiro relato de caso a ser publicado no Brasil.(AU)

Mupirocin pemphigus-like drug reaction in a dog

Background: Pharmacodermia is defined as adverse reaction in skin, mucosa and appendages, which generates morphofunctional alterations in cutaneous barrier, inducing autoimmune diseases, such as pemphigus foliaceous, which is known asthe most common autoimmune skin disease in dogs. This disease involves autoantibodies against desmoglein and desmocolinmolecules, being induced by the use of certain drugs. Mupirocin (pseudomonic acid A) is a broad-spectrum antibiotic withbacteriostatic activity, being effective against Gram-positive pathogens and used to control superficial bacterial folliculitis.Based on that, the aim of this study was to report a pemphigus-like lesions after topical use of mupirocin in dog.Case: An 1-year-old, uncastrated male, Poodle dog, weighing 13.8 kg was treated in a private clinic in Fortaleza. The maincomplaint was related to pruritus in abdominal and inguinal region, in addition of legs licking. Dermatological examination revealed melanic crusts, epidermal collars and diffuse pustules in inguinal, abdominal, perianal and thoraco-lumbarregions. The therapy was based on topical use of Mupirocin in form of 0.2% aquous spray. After drug administration, theanimal presented urticaria, diffuse epidermal collars, papulo-crusted and pustular lesions, which were more evident inabdominal and inguinal region. Nasal erythema, binocular blepharitis, apathy and fever were also observed. Cytologicalexamination and bacterial culture were performed, revealing inflammatory and acantholytic cells and no bacterial growth.Biopsy procedure revealed subcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatiblewith canine pemphigus foliaceous. The topical treatment of ocular lesions with 0.1% Tacrolimus associated with systemictreatment with high dose of prednisolone (1.2 mg kg-1)...

Mupirocin pemphigus-like drug reaction in a dog

Background: Pharmacodermia is defined as adverse reaction in skin, mucosa and appendages, which generates morphofunctional alterations in cutaneous barrier, inducing autoimmune diseases, such as pemphigus foliaceous, which is known asthe most common autoimmune skin disease in dogs. This disease involves autoantibodies against desmoglein and desmocolinmolecules, being induced by the use of certain drugs. Mupirocin (pseudomonic acid A) is a broad-spectrum antibiotic withbacteriostatic activity, being effective against Gram-positive pathogens and used to control superficial bacterial folliculitis.Based on that, the aim of this study was to report a pemphigus-like lesions after topical use of mupirocin in dog.Case: An 1-year-old, uncastrated male, Poodle dog, weighing 13.8 kg was treated in a private clinic in Fortaleza. The maincomplaint was related to pruritus in abdominal and inguinal region, in addition of legs licking. Dermatological examination revealed melanic crusts, epidermal collars and diffuse pustules in inguinal, abdominal, perianal and thoraco-lumbarregions. The therapy was based on topical use of Mupirocin in form of 0.2% aquous spray. After drug administration, theanimal presented urticaria, diffuse epidermal collars, papulo-crusted and pustular lesions, which were more evident inabdominal and inguinal region. Nasal erythema, binocular blepharitis, apathy and fever were also observed. Cytologicalexamination and bacterial culture were performed, revealing inflammatory and acantholytic cells and no bacterial growth.Biopsy procedure revealed subcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatiblewith canine pemphigus foliaceous. The topical treatment of ocular lesions with 0.1% Tacrolimus associated with systemictreatment with high dose of prednisolone (1.2 mg kg-1)...(AU)

Influência da temperatura e alterações na curva glicêmica de camundongos NOD produzidos no Instituto de Ciência e Tecnologia em Biomodelos da Fundação Oswaldo Cruz / Influence of temperature and changes on the glycemic curve of NOD mice produced at the Oswaldo Cruz Foundation/Science and Technology Institute

A diabetes faz parte de um grupo de doenças metabólicas que ocorre quando o pâncreas não produz, ou produz de forma insuficiente a insulina, ou quando o organismo não pode utilizar efetivamente a insulina produzida. Dentre os seus diferentes sub-tipos, a Diabetes Mellitus 1 (DM1) é de sintomatologia mais grave, sendo uma doença autoimune resultante da destruição parcial ou total das células β das ilhotas de Langerhans do pâncreas. O camundongo é o modelo mais bem caracterizado e modificado geneticamente para estudos em DM1, sendo a linhagem congênica mutante NOD (Non ObeseDiabetic) a mais utilizada atualmente. Dados observados previamente na colônia de camundongos NOD do ICTB/Fiocruz mostraram quea lguns indivíduos podem alcançar valores acima de 500 mg/dL, além de grandes desvios nas médias totais dos índices e isto pode estar correlacionado a alterações nas variáveis do macroambiente, dentre elas a temperatura. Este trabalho teve como objetivo determinar a curva glicêmica de camundongos NOD no ICTB/FIOCRUZ e correlacioná-la com alterações na temperatura do macroambiente. Os resultados indicam que variações na temperatura do ambiente influenciam os índices glicêmicos das fêmeas de camundongos NOD do ICTB/FIOCRUZ, afetando os padrões de expressão do DM1 neste modelo.

Diabetes is part of a group of metabolic diseases that occurs when the pancreas does not produce, or insufficiently produces insulin, or when the body cannot effectivelyuse the insulin it produces. Among its different subtypes, Diabetes Mellitus 1 (DM1)is the most severe, being an autoimmune disease resulting from the partial or total destruction of pancreatic Langerhans islet β cells. The mouse is the best characterized and genetically modified model for DM1 studies, being the NOD (Non ObeseDiabetic)mutant strain the most widely used today. Previously observed data in the ICTB / Fiocruz NOD mouse colony showed that some individuals can reach values above500 mg / dL, in addition to large deviations in the total index means and this may be correlated to changes in the macroenvironment variables. temperature. This study aimed to determine the glycemic curve of NOD mice in ICTB / FIOCRUZ and correlate it with changes in the temperature of the macroenvironment. The results indicate that variations in the ambient temperature influence the glycemic indexes of the female ICTB / FIOCRUZ NOD mice, affecting their DM1 expression patterns.